Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

154.65
-2.8900-1.83%
Post-market: 155.000.3500+0.23%19:44 EDT
Volume:1.22M
Turnover:189.49M
Market Cap:295.07B
PE:23.38
High:155.93
Open:155.93
Low:154.43
Close:157.54
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.02
T/O Rate:0.07%
Dividend:4.67
Dividend Rate:3.02%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:7.10
PE(LYR):21.63

Loading ...

Novartis to Take Earnings Hit From Generic Competition -- Market Talk

Dow Jones
·
Mar 30

Novartis announces two-year results from Phase III APPLAUSE-IgAN study

TIPRANKS
·
Mar 30

Novartis to buy biotech company Excellergy for up to $2B

TIPRANKS
·
Mar 27

Novartis (NVS) Stock Rises on $2B Excellergy Acquisition to Expand Allergy Portfolio

TIPRANKS
·
Mar 27

Novartis to Acquire US Biotech Firm Excellergy in Deal Worth Up to $2 Billion

Deep News
·
Mar 27

Novartis's Excellergy Payments Should Be Back-End Loaded -- Market Talk

Dow Jones
·
Mar 27

Novartis Acquires Excellergy for $2 Billion to Strengthen Food Allergy and Immune Disorder Portfolio

Stock News
·
Mar 27

Novartis to Acquire Excellergy For Up to $2 Billion

MT Newswires Live
·
Mar 27

Novartis Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Mar 27

Morgan Stanley Sticks to Its Buy Rating for Novartis (NVS)

TIPRANKS
·
Mar 26

Novartis Ag : Morgan Stanley Raises Target Price to $170 From $143

THOMSON REUTERS
·
Mar 26

Novartis's Share Strength Raises Bar for Drug Pipeline -- Market Talk

Dow Jones
·
Mar 23

Novartis price target raised to $178 from $163 at BofA

TIPRANKS
·
Mar 23

Novartis CEO Highlights AI's Growing Role in Amplifying Healthcare Innovation

Deep News
·
Mar 23

Novartis to Acquire Synnovation Therapeutics Breast Cancer Drug Assets for Up to $3 Billion

Stock News
·
Mar 20

Novartis to acquire Pikavation Therapeutics from Synnovation Therapeutics

TIPRANKS
·
Mar 20

Dow Jones Top Company Headlines at 5 AM ET: Super Micro Computer Employees Arrested for Alleged Sales to China | Unilever ...

Dow Jones
·
Mar 20

Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion -- Update

Dow Jones
·
Mar 20

Novartis (NVS) Receives a New Rating from Bernstein

TIPRANKS
·
Mar 20

Novartis Issues Debt Offering to Help Fund $12B Acquisition of Avidity Biosciences

Dow Jones
·
Mar 17